EFFICACY OF DUPILUMAB IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA AND WITH HIGH SLEEP DISTURBANCE: A POST HOC ANALYSIS FROM LIBERTY ASTHMA QUEST

被引：0
|
作者：
Maspero, J. [1 ]
Shafazand, S. [2 ]
Cole, J. [3 ]
Pavord, I. D. [4 ]
Busse, W. W. [5 ]
Msihid, J. [6 ]
Gall, R. [7 ]
Soler, X. [7 ]
Siddiqui, S. [7 ]
Khan, A. H. [6 ]
Gomez, L. D. P. [8 ]
Jacob-Nara, J. A. [9 ]
机构：
[1] Fdn CIDEA, Buenos Aires, DF, Argentina
[2] Miller Sch Med, Miami, FL USA
[3] OK Clin Res, Edmond, OK USA
[4] Univ Oxford, NIHR Oxford Biomed Res Ctr, Oxford, England
[5] Univ Wisconsin, UW Allergy Pulm & Crit Care Med, Madison, WI USA
[6] Sanofi, Chilly Mazarin, France
[7] Regeneron, Tarrytown, NY USA
[8] Sanofi, Reading, Berks, England
[9] Sanofi, Bridgewater, NJ USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCR53
引用
收藏
页码：S550 / S550
页数：1
相关论文
共 50 条
  • [21] Dupilumab Improves Lung Function in Children With Uncontrolled, Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE
    Bacharier, B. L.
    Guilbert, W. T.
    Katelaris, H. C.
    Deschildre, A.
    Liu, D.
    Mannent, P. L.
    Amin, N.
    Laws, E.
    Ruddy, M.
    Ortiz, B.
    Jacob-Nara, A. J.
    Deniz, Y.
    Rowe, J. P.
    Atenhan, A.
    Thakur, M.
    Lederer, J. D.
    Hardin, M.
    PNEUMOLOGIE, 2022, 76 : S40 - S40
  • [22] Dupilumab Improves Lung Function in Children with Uncontrolled, Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE
    Bacharier, L. B.
    Guilbert, T. W.
    Katelaris, C. G.
    Deschildre, A.
    Liu, D.
    Mannent, L. P.
    Laws, E.
    Ruddy, M.
    Jacob-Nara, J. A.
    Deniz, Y.
    Rowe, P. J.
    Lederer, D. J.
    Hardin, M.
    PEDIATRIC PULMONOLOGY, 2022, 57 : S97 - S98
  • [23] DUPILUMAB IMPROVES LUNG FUNCTION IN CHILDREN WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA: LIBERTY ASTHMA VOYAGE
    Bacharier, Leonard
    Guilbert, Theresa
    Katelaris, Constance
    Deschildre, Antoine
    Liu, Dongfang
    Mannent, Leda
    Amin, Nikhil
    Laws, Elizabeth
    Ruddy, Marcella
    Ortiz, Benjamin
    Jacob-Nara, Juby
    Deniz, Yamo
    Rowe, Paul
    Lederer, David
    Hardin, Megan
    CHEST, 2021, 160 (04) : 1885A - 1887A
  • [24] Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma
    Bacharier, Leonard B.
    Maspero, Jorge F.
    Katelaris, Constance H.
    Fiocchi, Alessandro G.
    Gagnon, Remi
    de Mir, Ines
    Jain, Neal
    Sher, Lawrence D.
    Mao, X.
    Liu, D.
    Zhang, Yi
    Khan, Asif H.
    Kapoor, Upender
    Khokhar, Faisal A.
    Rowe, Paul J.
    Deniz, Yamo
    Ruddy, Marcella
    Laws, Elizabeth
    Patel, Naimish
    Weinreich, David M.
    Yancopoulos, George D.
    Amin, Nikhil
    Mannent, Leda P.
    Lederer, David J.
    Hardin, Megan
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (24): : 2230 - 2240
  • [25] Dupilumab Treatment Produces Rapid and Sustained Improvements in FEV1 in Patients with Uncontrolled, Moderate-To-Severe Asthma from the LIBERTY ASTHMA QUEST Study
    Castro, M.
    Busse, W. W.
    Zhang, B.
    Maroni, J.
    Rowe, P.
    Amin, N.
    Pirozzi, G.
    Graham, N. M.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [26] DUPILUMAB DEMONSTRATES RAPID AND SUSTAINED IMPROVEMENTS IN DAILY ASTHMA-RELATED SYMPTOMS IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA: DATA FROM THE LIBERTY ASTHMA QUEST STUDY
    Douglass, Jo
    Langton, David
    Corren, Jonathan
    Castro, Mario
    Guillonneau, Sophie
    Chao, Jingdong
    Amin, Nikhil
    Graham, Neil M. H.
    Teper, Ariel
    Khan, Asif
    INTERNAL MEDICINE JOURNAL, 2018, 48 : 22 - 23
  • [27] SUSTAINED IMPROVEMENT IN ASTHMA CONTROL WITH DUPILUMAB TREATMENT IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE TYPE 2 ASTHMA: POST HOC ANALYSIS OF LIBERTY ASTHMA TRAVERSE OPEN-LABEL EXTENSION STUDY
    Busse, W. W.
    Pavord, I. D.
    Corren, J.
    Menzies-Gow, A.
    Heffler, E. G.
    Msihid, J.
    Siddiqui, S.
    Lederer, D. J.
    Hardin, M.
    Zhang, Y.
    Khan, A. H.
    Jacob-Nara, J. A.
    Deniz, Y.
    Rowe, P. J.
    VALUE IN HEALTH, 2022, 25 (07) : S553 - S554
  • [28] Dupilumab Reduces Severe Exacerbations and Improves Lung Function in Late-Onset, Uncontrolled, Moderate-to-Severe Asthma Patients Enrolled in the LIBERTY ASTHMA QUEST Study
    Hanania, N. A.
    Bateman, E. D.
    Castro, M.
    Pavord, I. D.
    Papi, A.
    FitzGerald, J. M.
    Maspero, J. F.
    Katelaris, C.
    Singh, D.
    Rice, M. S.
    Rowe, P.
    Lu, Y.
    Amin, N.
    Staudinger, H. W.
    Graham, N. M. H.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [29] Dupilumab associated with lower reports of respiratory infections in moderate-to-severe asthma - safety analysis from the LIBERTY ASTHMA QUEST study
    Geng, B.
    Busse, W. W.
    Chen, Z.
    Ortiz, B.
    Rowe, P.
    Deniz, Y.
    ALLERGY, 2020, 75 : 17 - 17
  • [30] Dupilumab Efficacy in Patients With Uncontrolled, Moderate-to-Severe Asthma by Immunoglobin E Levels at Baseline
    Carr, Warner
    Jackson, David J.
    Corren, Jonathan
    Bergmann, Karl-Christian
    Rice, Megan S.
    Deniz, Yamo
    Rowe, Paul
    Amin, Nikhil
    Teper, Ariel
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
12345